This inventor holds 3 USPTO granted patents. Top assignee: Korea Research Institute of Chemical Technology. Active years: 1997-2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1997-2006
Title: The Innovations of Inventor No-Sang Park
Introduction: No-Sang Park is a distinguished inventor based in Daejeon, South Korea. As a prominent figure in the field of chemical technology, he has developed innovative solutions that address critical medical challenges. With a total of three patents to his name, his contributions to the field are both significant and impactful.
Latest Patents: One of No-Sang Park's latest inventions includes the patent for 4-hydroxycinnamamide derivatives as antioxidants and pharmaceutical compositions containing them. This invention focuses on the superior antioxidant activity of these derivatives compared to existing compounds. It holds potential for treating neurodegenerative diseases such as aging, cancer, diabetes, ischemic stroke, Parkinson's disease, dementia, and Huntington's disease. This breakthrough underscores his commitment to advancing healthcare through innovation. Additionally, he has worked on phenylacetamide derivatives, further demonstrating his creativity in developing pharmaceutical solutions.
Career Highlights: No-Sang Park is affiliated with the Korea Research Institute of Chemical Technology, where he has made significant strides in research and development. His work consistently reflects a dedication to improving the efficacy of pharmaceutical treatments, impacting the broader medical field.
Collaborations: Throughout his career, No-Sang has collaborated with esteemed colleagues such as Young-Sik Jung and Churl-Min Seong. These collaborations have fostered an environment of innovation, enhancing the development and implementation of groundbreaking pharmaceutical solutions.
Conclusion: Inventor No-Sang Park exemplifies the spirit of innovation in the chemical technology sector. His ongoing efforts to develop effective treatments for serious medical conditions highlight his role as a leader in the field. With his advancements, he continues to inspire future generations of inventors and researchers dedicated to making a difference in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile